Sokolov Evgenij L'vovich (RU),Соколов Евгений Львович (RU),Chechik Andrej Anatol'evich (RU),Чечик Андрей Анатольевич (RU),Elokhovskij Vladimir Jur'evich (RU),Елоховский Владимир Юрьевич (RU),SOKOLOV EVGENIJ LVOVICH,Соколов Евгений Львович,CHECHIK ANDREJ ANATOLEVICH,Чечик Андрей Анатольевич,ELOKHOVSKIJ VLADIMIR JUREVICH,Елоховский Владимир Юрьевич
申请号：
RU2012106461/14
公开号：
RU0002518134C2
申请日:
2012.02.24
申请国别(地区):
RU
年份:
2014
代理人:
摘要：
FIELD: medicine.SUBSTANCE: invention refers to medicine. Determining an individual's blood glucose concentration is ensured by measuring high-frequency and low-frequency body region impedances successfully at pre-set intervals of time with using spaced electrodes fixed on the body. The measured high-frequency impedance provides the basis to determine a fluid volume in the body tissues between the electrodes, while the measured low-frequency impedance is used to determine an extracellular fluid volume in the body tissues between the electrodes. That is followed by deriving a metabolic component increment of the above extracellular fluid volume formed by the body energy carrier synthesis and recovery by calculating an increment of the above measured fluid volume in the body tissues between the electrodes as compared to the previous measured value, calculating a difference of the above increment of the fluid volume in the body tissues between the electrodes and the above increment of the extracellular fluid volume in the body tissues between the electrodes. A blood glucose increment is measured by standardising the above metabolic component increment of the extracellular fluid volume, while the individual's blood glucose concentration is determined by summing up the above glucose concentration increment and the blood glucose concentration derived at the previous stage of measurements. The glucose concentration at the first interval of time is determined by summing up the above blood glucose increment derived at the first interval of time and the initial glucose concentration.EFFECT: method enables continuous and non-invasive high-accuracy determination of the individual's blood glucose concentration.5 cl, 6 dwg, 3 exИзобретение относится к области медицины. Для определения концентрации глюкозы в крови человека, последовательно, через заданные интервалы времени измеряют значения импеданса участка тела человека на высокой частоте и низкой частоте с использованием закре
